226 related articles for article (PubMed ID: 15892300)
21. Ubiquitin immunohistochemistry of frontotemporal lobar degeneration differentiates cases with and without motor neuron disease.
Katsuse O; Dickson DW
Alzheimer Dis Assoc Disord; 2005; 19 Suppl 1():S37-43. PubMed ID: 16317257
[TBL] [Abstract][Full Text] [Related]
22. Unexpected abundance of pathological tau in progressive supranuclear palsy white matter.
Zhukareva V; Joyce S; Schuck T; Van Deerlin V; Hurtig H; Albin R; Gilman S; Chin S; Miller B; Trojanowski JQ; Lee VM
Ann Neurol; 2006 Sep; 60(3):335-45. PubMed ID: 16823854
[TBL] [Abstract][Full Text] [Related]
23. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
[TBL] [Abstract][Full Text] [Related]
24. Argyrophilic Grain Pathology in Frontotemporal Lobar Degeneration: Demographic, Clinical, Neuropathological, and Genetic Features.
Gil MJ; Manzano MS; Cuadrado ML; Fernández C; Góméz E; Matesanz C; Calero M; Rábano A
J Alzheimers Dis; 2018; 63(3):1109-1117. PubMed ID: 29758948
[TBL] [Abstract][Full Text] [Related]
25. Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study.
Zhukareva V; Sundarraj S; Mann D; Sjogren M; Blenow K; Clark CM; McKeel DW; Goate A; Lippa CF; Vonsattel JP; Growdon JH; Trojanowski JQ; Lee VM
Acta Neuropathol; 2003 May; 105(5):469-76. PubMed ID: 12677447
[TBL] [Abstract][Full Text] [Related]
26. Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy.
Liu WK; Le TV; Adamson J; Baker M; Cookson N; Hardy J; Hutton M; Yen SH; Dickson DW
Ann Neurol; 2001 Oct; 50(4):494-502. PubMed ID: 11601500
[TBL] [Abstract][Full Text] [Related]
27. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
28. How to demix Alzheimer-type and PSP-type tau lesions out of their mixture -hybrid approach to dissect comorbidity.
Ebashi M; Ito Y; Uematsu M; Nakamura A; Hirokawa K; Kamei S; Uchihara T
Acta Neuropathol Commun; 2019 May; 7(1):71. PubMed ID: 31060611
[TBL] [Abstract][Full Text] [Related]
29. Differential vulnerability of the dentate gyrus to tauopathies in dementias.
Kawles A; Minogue G; Zouridakis A; Keszycki R; Gill N; Nassif C; Coventry C; Zhang H; Rogalski E; Flanagan ME; Castellani R; Bigio EH; Mesulam MM; Geula C; Gefen T
Acta Neuropathol Commun; 2023 Jan; 11(1):1. PubMed ID: 36597124
[TBL] [Abstract][Full Text] [Related]
30. Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration.
Martínez-Maldonado A; Ontiveros-Torres MÁ; Harrington CR; Montiel-Sosa JF; Prandiz RG; Bocanegra-López P; Sorsby-Vargas AM; Bravo-Muñoz M; Florán-Garduño B; Villanueva-Fierro I; Perry G; Garcés-Ramírez L; de la Cruz F; Martínez-Robles S; Pacheco-Herrero M; Luna-Muñoz J
J Alzheimers Dis; 2021; 79(4):1517-1531. PubMed ID: 33459640
[TBL] [Abstract][Full Text] [Related]
31. The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy.
Hogg M; Grujic ZM; Baker M; Demirci S; Guillozet AL; Sweet AP; Herzog LL; Weintraub S; Mesulam MM; LaPointe NE; Gamblin TC; Berry RW; Binder LI; de Silva R; Lees A; Espinoza M; Davies P; Grover A; Sahara N; Ishizawa T; Dickson D; Yen SH; Hutton M; Bigio EH
Acta Neuropathol; 2003 Oct; 106(4):323-36. PubMed ID: 12883828
[TBL] [Abstract][Full Text] [Related]
32. The Role of Tau Proteoforms in Health and Disease.
Waheed Z; Choudhary J; Jatala FH; Fatimah ; Noor A; Zerr I; Zafar S
Mol Neurobiol; 2023 Sep; 60(9):5155-5166. PubMed ID: 37266762
[TBL] [Abstract][Full Text] [Related]
33. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy.
Katsuse O; Iseki E; Arai T; Akiyama H; Togo T; Uchikado H; Kato M; de Silva R; Lees A; Kosaka K
Acta Neuropathol; 2003 Sep; 106(3):251-60. PubMed ID: 12802605
[TBL] [Abstract][Full Text] [Related]
34. Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases?
Sha S; Hou C; Viskontas IV; Miller BL
Nat Clin Pract Neurol; 2006 Dec; 2(12):658-65. PubMed ID: 17117169
[TBL] [Abstract][Full Text] [Related]
35. Machine learning-based decision tree classifier for the diagnosis of progressive supranuclear palsy and corticobasal degeneration.
Koga S; Zhou X; Dickson DW
Neuropathol Appl Neurobiol; 2021 Dec; 47(7):931-941. PubMed ID: 33763863
[TBL] [Abstract][Full Text] [Related]
36. [Neuropathology of tauopathy].
Yoshida M
Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931
[TBL] [Abstract][Full Text] [Related]
37. [Neuropathology of frontotemporal dementia].
Murayama S
Rinsho Shinkeigaku; 2008 Nov; 48(11):998. PubMed ID: 19198143
[TBL] [Abstract][Full Text] [Related]
38. Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and alpha-synuclein pathology.
Newman J; Rissman RA; Sarsoza F; Kim RC; Dick M; Bennett DA; Cotman CW; Rohn TT; Head E
Acta Neuropathol; 2005 Aug; 110(2):135-44. PubMed ID: 15986225
[TBL] [Abstract][Full Text] [Related]
39. Atypical progressive supranuclear palsy with corticospinal tract degeneration.
Josephs KA; Katsuse O; Beccano-Kelly DA; Lin WL; Uitti RJ; Fujino Y; Boeve BF; Hutton ML; Baker MC; Dickson DW
J Neuropathol Exp Neurol; 2006 Apr; 65(4):396-405. PubMed ID: 16691120
[TBL] [Abstract][Full Text] [Related]
40. Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy.
Kertesz A; Munoz D
Dement Geriatr Cogn Disord; 2004; 17(4):282-6. PubMed ID: 15178937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
